Undiscovered Equities Top 10 2009 Average Return 168% Prices аѕ οf December 31, 2011 Company Reference Price Recent Price Total Return Ultra Petroleum (UPL) $34.03 $52.64 55% Manas Petroleum (MNAP) $0.26 $0.55 120% Gran Tierra Energy, Inc. (GTE) $2.56 $5.94 132% InterOil (IOC) $11.75 $77.29 558% Southwestern Energy (SWN) $29.97 $49.99 69% American Oil & [...]
Undiscovered Equities Top 10 2010 Average Return 57.7% Prices as of December 31, 2010 Company Reference Price Recent Price Total Return Endeavour Financial (TSX: EDV) $1.77 $2.81 +58.7% Environmental Infrastructure Holdings Corp. (OTCBB: EIHC) $0.26 $0.08 -69.2% Far East Energy Corporation (OTCBB: FEEC) $0.46 $0.70 +52.1% Gran Tierra Energy Inc. (NYSE Amex: GTE, TSX: GTE) [...]
Undiscovered Equities’ Top Picks for 2011 UndiscoveredEquites.com, Boca Raton, FL December 31st, 2011 |About stocks: AAB/BPZ/CZE/CVAT/FEEC/FXEN/HUSA/INTK/MNAP/WNDM Undiscovered Equities would like to thank all of our subscribers for their kind words and support over this past year. All in all, 2011 was another great year and we expect 2011 to be even better. As promised, [...]
Dear fellow investor, My name is Kevin McKnight and I am the president and editor of Undiscovered Equities, Inc.. Since the early ‘90’s I have had an intense thirst for knowledge about the equity and financial markets and in the ensuing decade and a half I have established a worldwide network of experts and have [...]
TULSA, Okla., March 2, 2011 – 3DIcon Corporation (OTCBB:TDCP – News), a developer of volumetric, three-dimensional projection and display technologies, today announced it has appointed Dr. Brian G. Hoover as its Vice President of Technology Development. Dr. Hoover will work with 3DIcon’s Chief Technology Officer, Dr. Hakki Refai, and Technology Advisory Board Chairman, Vivek Bhaman, [...]
Wound Management Technologies, Inc., through its subsidiaries, distributes collagen-based wound care products. The company offers CellerateRX, a collagen product in gel and powder forms for the diabetic community to treat acute and chronic wounds. It markets CellerateRx for pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree [...]
© 2012
Undiscovered Equities. All Rights Reserved.
Log in
-
